Cargando…

Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib, has greatly affected clinical outcomes in non-small cell lung cancer (NSCLC) patients. The long noncoding RNAs (lncRNAs) are known to regulate tumorigenesis and cancer progression, but their con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhenyao, Chen, Qinnan, Cheng, Zhixiang, Gu, Jingyao, Feng, Wenyan, Lei, Tianyao, Huang, Jiali, Pu, Jiaze, Chen, Xin, Wang, Zhaoxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560854/ https://www.ncbi.nlm.nih.gov/pubmed/33056982 http://dx.doi.org/10.1038/s41419-020-03047-y

Ejemplares similares

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer: HMGB1-mediated autophagy promotes gefitinib resistance
por: Lei, Tianyao, et al.
Publicado: (2022)

Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression
por: Chen, Zhenyao, et al.
Publicado: (2020)

Long noncoding RNA actin filament‐associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine‐specific demethylase 1 and repressing HMG box‐containing protein 1 in non‐small‐cell lung cancer
por: Yu, Shanxun, et al.
Publicado: (2019)

The pseudogene DUXAP10 contributes to gefitinib resistance in NSCLC by repressing OAS2 expression: DUXAP10 contributes to gefitinib resistance by repressing OAS2
por: Ren, Shengnan, et al.
Publicado: (2022)

Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression
por: Chen, Zhenyao, et al.
Publicado: (2017)

LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
por: Xu, Tianwei, et al.
Publicado: (2020)

Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC
por: Ye, Yunyao, et al.
Publicado: (2020)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

Combined treatment with N‐acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line
por: Li, Jun, et al.
Publicado: (2019)

Characterization of circRNAs in established osimertinib-resistant non-small cell lung cancer cell lines
por: Chen, Xin, et al.
Publicado: (2023)

Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4
por: Yin, Yakun, et al.
Publicado: (2018)

The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations
por: Xin, Shuang, et al.
Publicado: (2015)

Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib‐effective patients with advanced NSCLC
por: Qin, Yijia, et al.
Publicado: (2016)

Pemetrexed induces ROS generation and cellular senescence by attenuating TS‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC
por: Chen, Yun, et al.
Publicado: (2023)

Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line
por: Yan, Dong, et al.
Publicado: (2015)

The Role of lncRNA PCAT6 in Cancers
por: Wang, Siying, et al.
Publicado: (2021)

Fasudil Increased the Sensitivity to Gefitinib in NSCLC by Decreasing Intracellular Lipid Accumulation
por: Liao, Tingting, et al.
Publicado: (2022)

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
por: Zhao, Hongbo, et al.
Publicado: (2018)

Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5
por: Liu, Bin, et al.
Publicado: (2017)

Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells
por: Zhu, Yinsong, et al.
Publicado: (2015)

An innovative CASC training redesign – ‘experience of virtual mock CASC exam’
por: Rankin, Jennifer, et al.
Publicado: (2021)

Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
por: Yue, Jinnan, et al.
Publicado: (2018)

Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma
por: Liao, Ling, et al.
Publicado: (2023)

DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
por: Lee, S, et al.
Publicado: (2010)

Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
por: Freitas, Jaime, et al.
Publicado: (2023)

Long non-coding RNA CASC19 is associated with the progression and prognosis of advanced gastric cancer
por: Wang, Wen-Jie, et al.
Publicado: (2019)

Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016)

FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy
por: Guan, Shaoxing, et al.
Publicado: (2022)

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition
por: Yang, Xiaomin, et al.
Publicado: (2023)

SKA1 promotes tumor metastasis via SAFB-mediated transcription repression of DUSP6 in clear cell renal cell carcinoma
por: Pu, Yan, et al.
Publicado: (2022)

EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC
por: Meng, Jiao, et al.
Publicado: (2019)

A meta-analysis of the safety and effectiveness of pemetrexed compared with gefitinib for pre-treated advanced or metastatic NSCLC
por: Lu, Xiaoxin, et al.
Publicado: (2020)

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
por: Tiseo, M, et al.
Publicado: (2010)

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy
por: Li, Yang-Ling, et al.
Publicado: (2018)

The Effect of Gefitinib on Treatment Necessity and Prognosis of NSCLC Patients with Early EGFR Mutations
por: Song, Ruiqiang, et al.
Publicado: (2022)

Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis
por: He, Tianyu, et al.
Publicado: (2017)

A national CASC course
por: Ramesh, Yathooshan, et al.
Publicado: (2021)

Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment
por: Sun, Xia, et al.
Publicado: (2021)

Long non‐coding RNA CASC8 polymorphisms are associated with the risk of esophageal cancer in a Chinese population
por: Sang, Yonghua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2qdcq1qj1ibl0f9fr6qa5hqr34